BlackRock Science and Technology Trust II (BSTZ) Peer Comparison
$26.84
As on 22-Oct-2026 15:42EDT
Market cap
$2,089 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
6.6
P/B Ratio
1.2
Div. Yield
0 %
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2,089 | 2,855 | 1,842 | 1,543 | 1,396 |
Revenue ($ Mln) |
266 | 948 | 205 | 24 | 225 |
Net Profit ($ Mln) |
314.36 | -375.00 | 254.31 | 376.65 | 221.99 |
Net Margin (%) |
-- | -39.56 | -- | 1,542.35 | -- |
RoE (%) |
20.33 | -6.75 | 13.09 | 20.46 | 13.39 |
Price to Earnings |
6.56 | -- | 5.43 | 4.06 | 5.48 |
Price-To-Book |
1.22 | 0.60 | 0.91 | 0.89 | 0.94 |
Income Statement ($ Mln)
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
265.96 | 1,171.00 | 204.61 | 163.88 | 225.03 |
|
Cost of Revenue
|
20.58 | 356.00 | 8.19 | 13.88 | 1.43 |
|
Gross Profit
|
245.38 | 815.00 | 196.42 | 150.00 | 223.60 |
|
Operating Expenses
|
-69.41 | 235.00 | -57.89 | -189.78 | 1.61 |
|
Operating Profit (EBIT)
|
314.79 | 580.00 | 254.31 | 339.84 | 221.99 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
314.36 | 23.00 | 254.31 | 339.84 | 221.99 |
|
Provision for Tax
|
-- | 12.00 | -- | -- | -- |
|
Profit after Tax (Net Income)
|
314.36 | 11.00 | 254.31 | 339.84 | 221.99 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 11.00 | -- | -- | -- |
Liabilities ($ Mln)
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,717.10 | 5,849.00 | 1,982.80 | 1,756.14 | 1,595.29 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
18.50 | 7,880.00 | 2.44 | 16.88 | 93.32 |
|
Current Liabilities
|
17.50 | -- | 2.04 | 0.33 | 277.11 |
|
Total Liabilities
|
1,753.11 | 13,729.00 | 1,985.24 | 1,773.36 | 1,965.72 |
Assets ($ Mln)
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,721.20 | 13,548.00 | 1,972.27 | 1,772.94 | 1,958.96 |
|
Current Assets
|
31.91 | 181.00 | 12.97 | 0.42 | 6.75 |
|
Total Assets
|
1,753.11 | 13,729.00 | 1,985.24 | 1,773.36 | 1,965.72 |
|
Total Debt*
|
17.50 | 7,634.00 | -- | 1.80 | -- |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-47.75 | 592.00 | -- | -- | 329.51 |
|
Cash Flow from Investing Activities
|
324.34 | 236.00 | -- | -- | -- |
|
Cash from Financing Activities
|
-256.13 | -679.00 | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
20.17 | 0.08 | 13.09 | 20.56 | 13.39 |
|
ROE (%)
|
20.33 | 0.18 | 13.09 | 20.58 | 13.39 |
|
ROA (%)
|
18.21 | 0.08 | 13.07 | 20.36 | 11.41 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
118.20 | 0.94 | 124.29 | 207.37 | 98.65 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.03 | 0.05 | -0.36 | -0.35 | 0.14 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
15.45 | -98.12 | -20.71 | 38.45 | 14.18 |
|
EPS Growth (%)
|
-0.42 | -0.98 | -0.21 | 0.35 | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
4.94 | 377.07 | 6.87 | 4.15 | -- |
|
Price / Book Value
|
0.91 | 0.71 | 0.88 | 0.80 | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
4.90 | 22.70 | 6.87 | 4.15 | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.01 | 1.31 | -- | 0.00 | -- |
|
Short term debt to equity ratio
|
0.01 | 0.00 | -- | -- | -- |
|
Current Ratio
|
1.82 | -- | 6.37 | 1.26 | 0.02 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
-- | 1.05 | -- | -- | -- |
Operating Efficiency Ratios
| BlackRock Science and Technology Trust II (BSTZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.59 | 35.10 | 6.25 | 1.57 | -- |
|
Asset Turnover
|
0.15 | 0.08 | 0.11 | 0.10 | 0.12 |
|
Receivable days
|
1.18 | 122.27 | 21.00 | 15.90 | 18.07 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
249.67 | 100.03 | 102.43 | 9.21 | 59,183.92 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |